These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8029476)

  • 1. Semi-synthetic derivatives of 16-membered macrolide antibiotics.
    Kirst HA
    Prog Med Chem; 1994; 31():265-95. PubMed ID: 8029476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the field of 16-membered macrolide antibiotics.
    Cui W; Ma S
    Mini Rev Med Chem; 2011 Oct; 11(12):1009-18. PubMed ID: 21861810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of 4''-O-acyl derivatives of 14- and 15-membered macrolides linked to omega-quinolone-carboxylic unit.
    Skugor MM; Stimac V; Palej I; Lugarić D; Paljetak HC; Filić D; Modrić M; Dilović I; Gembarovski D; Mutak S; Eraković Haber V; Holmes DJ; Ivezić-Schoenfeld Z; Alihodzić S
    Bioorg Med Chem; 2010 Sep; 18(17):6547-58. PubMed ID: 20621489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 16-membered macrolide antibiotics: a review.
    Arsic B; Barber J; Čikoš A; Mladenovic M; Stankovic N; Novak P
    Int J Antimicrob Agents; 2018 Mar; 51(3):283-298. PubMed ID: 28668674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics.
    Nakajima Y; Jánosi L; Endou K; Matsuoka M; Hashimoto H
    J Pharmacobiodyn; 1992 Jun; 15(6):319-24. PubMed ID: 1432570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry and mode of action of macrolides.
    Mazzei T; Mini E; Novelli A; Periti P
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():1-9. PubMed ID: 7683018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cladinose analogues of sixteen-membered macrolide antibiotics. IV. Improved therapeutic effects of 4-O-acyl-L-cladinose analogues of sixteen-membered macrolide antibiotics.
    Ajito K; Kurihara K; Shibahara S; Hara O; Okonogi T; Kikuchi N; Araake M; Suzuki H; Omoto S; Inouye S
    J Antibiot (Tokyo); 1997 Feb; 50(2):150-61. PubMed ID: 9099226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various novel erythromycin derivatives obtained by different modifications: recent advance in macrolide antibiotics.
    Ma C; Ma S
    Mini Rev Med Chem; 2010 Apr; 10(4):272-86. PubMed ID: 20470243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature nurtures the design of new semi-synthetic macrolide antibiotics.
    Fernandes P; Martens E; Pereira D
    J Antibiot (Tokyo); 2017 May; 70(5):527-533. PubMed ID: 27899792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cladinose analogues of sixteen-membered macrolide antibiotics. VI. Synthesis of metabolically programmed, highly potent analogues of sixteen-membered macrolide antibiotics.
    Kurihara KI; Ajito K; Shibahara S; Hara O; Araake M; Omoto S; Inouye S
    J Antibiot (Tokyo); 1998 Aug; 51(8):771-85. PubMed ID: 9766469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-synthetic derivatives of erythromycin.
    Kirst HA
    Prog Med Chem; 1993; 30():57-88. PubMed ID: 8303037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolides: present and future. An appraisal of in-vitro activity and pharmacokinetic behavior.
    Furneri PM; Nicoletti G
    J Chemother; 1991 Jan; 3 Suppl 1():24-7. PubMed ID: 12041776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide Hybrid Compounds: Drug Discovery Opportunities in Anti- Infective and Anti-inflammatory Area.
    Paljetak HC; Tomaskovic L; Matijasic M; Bukvic M; Fajdetic A; Verbanac D; Peric M
    Curr Top Med Chem; 2017; 17(8):919-940. PubMed ID: 27697049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAN-1323 C and D, new concanamycin-group antibiotics; detection of the angiostatic activity with a wide range of macrolide antibiotics.
    Ishii T; Hida T; Iinuma S; Muroi M; Nozaki Y
    J Antibiot (Tokyo); 1995 Jan; 48(1):12-20. PubMed ID: 7532643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in metabolic engineering of macrolide antibiotics].
    Hao T; He W
    Sheng Wu Gong Cheng Xue Bao; 2021 May; 37(5):1737-1747. PubMed ID: 34085452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14- and 15-membered lactone macrolides and their analogues and hybrids: structure, molecular mechanism of action and biological activity.
    Janas A; Przybylski P
    Eur J Med Chem; 2019 Nov; 182():111662. PubMed ID: 31499358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolides: structures and microbial targets.
    Retsema J; Fu W
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S3-10. PubMed ID: 11574188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.